References
- Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294–4301.
- Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709–720.
- Hama T, Tokumaru Y, Fujii M, et al. Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology. 2014;87(3):173–182.
- Yasui T, Morii E, Yamamoto Y, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One. 2014;9(4):e95364.
- Graboyes EM, Sinha P, Thorstad WL, et al. Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach. Head Neck. 2015;37(11):1603–1611.
- Dziegielewski PT, O'Connell DA, Szudek J, et al. Neck metastases in oropharyngeal cancer: Necessity and extent of bilateral treatment. Head Neck. 2013;35:1461–1467.
- Cho KJ, Joo YH, Sun DI, et al. Management of cervical lymph node metastasis in tonsillar squamous cell carcinoma: is it necessary to treat node-negative contralateral neck? Auris Nasus Larynx. 2011;38(4):501–507.
- Lim YC, Lee SY, Lim JY, et al. Management of contralateral N0 neck in tonsillar squamous cell carcinoma. Laryngoscope. 2005;115:1672–1675.
- Kato MG, Ellis MA, Nguyen SA, et al. Predictors of contralateral-bilateral nodal disease in oropharyngeal cancer: a national cancer data base study. Head Neck. 2018;40(2):338–348.
- Tritter AG, Mehta V, Samuelson M, et al. Incidence of contralateral-bilateral nodes in the human papillomavirus era. Laryngoscope. 2017;127(6):1328–1333.
- Gershowitz J, Chao HH, Doucette A, et al. Risk of post-operative, pre-radiotherapy contralateral neck recurrence in patients treated with surgery followed by adjuvant radiotherapy for human papilloma virus-associated tonsil cancer. Br J Radiol. 2019;92(1104):20190466.
- Park JO, Lee YS, Joo YH, et al. Can the transoral approach secure a cancer-free deep margin in tonsil cancer? Oral Oncol. 2012;48(7):658–661.
- Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.
- Fakhry C, Westra WH, Li S, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261–269.
- Licitra L, Perrone F, Bossi P, et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24(36):5630–5636.
- Vila PM, Stucken CL, Morris LG, et al. Reduced impact of nodal metastases as a prognostic factor for tonsil cancer in the HPV era. Eur Arch Otorhinolaryngol. 2014;271(9):2523–2529.
- Miccio JA, Verma V, Kelly J, et al. Impact of contralateral lymph nodal involvement and extranodal extension on survival of surgically managed HPV-positive oropharyngeal cancer staged with the AJCC eighth edition. Oral Oncol. 2019;99:104447.
- McMullen CP, Garneau J, Weimar E, et al. Occult contralateral nodal disease in oropharyngeal squamous cell carcinoma patients undergoing primary TORS with bilateral neck dissection. Oral Oncol. 2019;93:96–100.
- Zenga J, Jackson RS, Graboyes EM, et al. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma. Laryngoscope. 2017;127(3):623–630.